DOI: 10.4244/EIJV9I4A86

Late aortic perforation with a fractured ATRIASEPT II device resulting in life-threatening tamponade

Francisco José Hernández Pérez1*, MD; José Antonio Fernández Díaz1, MD; Carlos García Montero2, MD, PhD; Arturo García Touchard1, MD; Juan Francisco Oteo Domínguez1, MD; José Ramón Domínguez Puente1, MD; Javier Goicolea Ruigómez1, MD

A 32-year-old female suffered a transient ischaemic attack (TIA) in the territory of the middle cerebral artery, and a patent foramen ovale (PFO) and an atrial septal aneurysm (ASA) were diagnosed using transoesophagic echocardiography (TEE). A 20 mm ATRIASEPT™ (Cardia Inc., Eagan, MN, USA) device was successfully implanted.

Three months later the patient was admitted to hospital in shock with cardiac tamponade. Pericardiocentesis was immediately performed but haemodynamic instability meant transferring the patient to the operating room (OR) for emergency surgery.

Intraoperatively, lacerations in the aorta and the top of the right atria were identified (Figure 1). Defects were provisionally repaired and the patient was stabilised in the intensive care unit. Echocardiography and fluoroscopy showed a correct position and no structural damage of the device. Days later, on-pump surgery was performed and the device was removed. The ATRIASEPT device showed the following defect in the structure: several of the coupler wires attached to one of the right/centre struts were fractured (Figure 2). This defect had eroded the right atrium and aortic root causing the damage.

Figure 1. Intraoperative image. The arrow points to the wires that caused the lacerations in the aorta and the top of the right atria.

Figure 2. Details of the device removed. Several of the coupler wires attached to one of the right/centre struts were fractured.

The patient recovered well in the postoperative period and was discharged 25 days later, uneventfully. In the follow-up performed 12 months later the patient was well without sequelae.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 9 Number 4
Aug 23, 2013
Volume 9 Number 4
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-24-00010 Apr 15, 2024
Timing of revascularisation in acute coronary syndromes with multivessel disease – two sides of the same coin
Stähli B and Stehli J
free

Editorial

10.4244/EIJ-E-24-00006 Apr 15, 2024
The miracle of left ventricular recovery after transcatheter aortic valve implantation
Dauerman H and Lahoud R
free

Research Correspondence

10.4244/EIJ-D-23-01046 Apr 15, 2024
Feasibility and safety of transcaval venoarterial extracorporeal membrane oxygenation in severe cardiogenic shock
Giustino G et al

State-of-the-Art

10.4244/EIJ-D-23-00836 Apr 15, 2024
Renal denervation in the management of hypertension
Lauder L et al
free

Original Research

10.4244/EIJ-D-23-00643 Apr 15, 2024
A study of ChatGPT in facilitating Heart Team decisions on severe aortic stenosis
Salihu A et al
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved